SCHEMBL10184157

SCHEMBL10184157

COc1ccccc1NCC(=O)N(c1cccc(F)c1)C1C(=O)N(C2CCCCC2)c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.38
▸ LMNA P02545 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ OPRM1 P35372 2/20 0.37
▸ OPRK1 P41145 2/20 0.37
▸ OPRL1 P41146 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ CCR3 P51677 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ TSHR P16473 2/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ HTR7 P34969 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ DRD4 P21917 1/20 0.34
▸ DRD3 P35462 1/20 0.34
▸ TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183927 0.90 OPRM1 (0.36) MAPTLMNAKMT2AOPRM1OPRK1
SCHEMBL10183740 0.88 CYP3A4 (0.40) LMNAKMT2AOPRM1OPRK1OPRL1
SCHEMBL10183669 0.87 CCKBR (0.41) MAPTLMNAKMT2AOPRM1OPRK1
SCHEMBL10185977 0.86 OPRM1 (0.39) MAPTLMNAKMT2AOPRM1OPRK1
SCHEMBL10183782 0.86 OPRM1 (0.40) MAPTLMNAOPRM1OPRK1OPRL1
SCHEMBL10183924 0.86 OPRK1 (0.38) MAPTLMNAKMT2AOPRM1OPRK1
SCHEMBL10183654 0.83 IDH1 (0.38) MAPTLMNAOPRM1OPRK1OPRL1
SCHEMBL10184071 0.83 OPRM1 (0.37) MAPTLMNAOPRM1OPRK1OPRL1
SCHEMBL10185838 0.83 NPC1 (0.35) MAPTLMNAOPRM1OPRK1OPRL1
SCHEMBL10183289 0.82 KMT2A (0.43) KMT2AOPRM1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback